Publications by authors named "Andreea Parosanu"

Claim this Profile
S
Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review.
Constantin Radu Vrabie, Andreea Ioana Parosanu, Cornelia Nitipir

Medicina (Kaunas)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.
Ana Maria Popa, Mihaela Andreea Stejeroiu, Cristian Iaciu, Mihaela Olaru, Cristina Orlov Slavu, Andreea Parosanu

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy?
Andreea Ioana Parosanu, Cornelia Nititpir, Ioana Miruna Stanciu, Catalin Baston

Biomedicines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma.
Catalin Baston, Andreea Ioana Parosanu, Ioana-Miruna Stanciu, Cornelia Nitipir

Biomedicines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the Diagnosis and Treatment of Oral Amelanotic Malignant Melanoma: A Case Report.
Oana A Rosu, Madalina I Tolea, Andreea I Parosanu, Miruna I Stanciu, Horia T Cotan

Cureus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.
Catalin Baston, Andreea Ioana Parosanu, Mihaela Mihai, Oana Moldoveanu, Ioana Miruna Stanciu

Diagnostics (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania.
Ana Maria Popa, Mihaela Andreea Stejeroiu, Cristian Iaciu, Mihaela Olaru, Cristina Orlov Slavu, Andreea Parosanu

Cureus· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis.
Radu Andrei Emilescu, Mariana Jinga, Horia Teodor Cotan, Ana Maria Popa, Cristina Maria Orlov-Slavu, Andreea Ioana Parosanu

Int J Mol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer-A Systematic Review of Randomized Phase II and III Clinical Trials.
Ioana-Miruna Stanciu, Andreea Ioana Parosanu, Cornelia Nitipir

Biomolecules· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers.
Andreea Ioana Parosanu, Catalin Baston, Ioana Miruna Stanciu, Cristina Florina Parlog, Cornelia Nitipir

Diagnostics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?
Cristina-Florina Pîrlog, Raluca Costache, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru

Diagnostics (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review.
Ioana-Miruna Stanciu, Cristina Florina Pirlog, Andrei-Wilhelm Anghel, Andreea Ioana Parosanu, Cristina Mihaela Olaru

Medicina (Kaunas)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature.
Ioana-Miruna Stanciu, Andreea Ioana Parosanu, Cristina Orlov-Slavu, Ion Cristian Iaciu, Ana Maria Popa

Diagnostics (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma.
Andreea Ioana Parosanu, Cristina Florina Pirlog, Cristina Orlov Slavu, Ioana Miruna Stanciu, Horia-Teodor Cotan

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors-A Systematic Review of the Literature.
Cristina-Florina Pîrlog, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru, Ana Maria Popa

Curr Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy.
Andreea Parosanu, Ioana Miruna Stanciu, Cristina Pirlog, Cristina Orlov Slavu, Horia Cotan

Cureus· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature.
Andreea Parosanu, Cristina Orlov Slavu, Cristina Pirlog, Ioana M Stanciu, Cornelia Nitipir

Cureus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer.
Cristina-Florina Pirlog, Horia Teodor Cotan, Andreea Parosanu, Cristina Orlov Slavu, Ana Maria Popa

Cureus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort study.
Cornelia Nitipir, Andreea Ioana Parosanu, Mihaela Olaru, Ana Maria Popa, Cristina Pirlog

Exp Ther Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization Protocol to Carboplatin: A Technical Report.
Cornelia Nitipir, Andreea Parosanu, Ana Maria Popa, Horia Cotan, Mihaela Olaru

Cureus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of the Administration of FOLFIRINOX Beyond Six Months in Advanced Pancreatic Adenocarcinoma: A Cohort Study.
Cornelia Nitipir, Radu Vrabie, Andreea Ioana Parosanu, Raluca Tulin, Bogdan Cretu

Cureus· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis